Cristiana Campa PhD

Cristiana Campa is currently Head of Quality by Design Integration at GSK Vaccines. In this role, Cristiana is leading a team with members in Belgium, Italy and US sites, aimed at the definition of an integrated approach for product, process and analytical development according to QbD principles, after acquisition of Novartis Vaccines by GSK. She has also been a technical lead for the implementation of QbD in Technical Development and Manufacturing Science and Technology at Novartis Vaccines since 2012. Cristiana joined the Novartis in December, 2006, as an analytical project manager in Technical Development, Italy, leading analytical investigations, characterizations and methods development/ validation. Since February 2013, she has been the Head of Analytical Development in Technical Development, Italy.

Cristiana has a PhD in Chemistry (2000, University of Basilicata, Italy) with a focus on analytical chemistry of carbohydrates. Early in her career she worked as a Post-Doc at Department of Biochemistry, Biophysics and Macromolecular Chemistry, University of Trieste (2000-2002), Italy, studying synthetic approaches & characterization of glycoconjugates. In the period 2002-2006 she worked at Bracco Imaging SpA (Trieste unit), first as a senior researcher and then as head of laboratory, focusing on the study of new glycosylated contrast agents and in the support for commercial manufacturing.